1. A low-carbohydrate high-fat (LCHF) diet improved glycemic and weight control in patients with type two diabetes mellitus (T2DM) compared ...
1. In a systematic review and meta-analysis of observational studies on patients with diabetes, metformin use was associated with a ...
1. SGLT2 inhibitors reduced the risk of kidney disease progression by 37% overall, with comparable effects in patients with and ...
1. For sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP1) receptor agonists to be used as first-line agents for type ...
1. Compared to sitagliptin and glimepiride, glargine and liraglutide were more effective in achieving target glycated hemoglobin levels in patients ...
![Type I diabetes not associated with early menopause [OVADIA study]](https://s25qthea.wpenginepowered.com/wp-content/uploads/2014/12/diabetes1_edited-350x250.jpg)
1. No significant differences in vascular complications of diabetes were seen in patients using metformin and adjunctive glargine, liraglutide, glimepiride, ...
1. At week 16, average neuropathic pain score decreased for all three treatment groups. 2. Pain reduction was greater in ...
1. Patients with diabetes and high polygenic risk scores are at an increased risk of developing gestational diabetes. 2. Assessment ...
1. Faricimab every 8 weeks and faricimab per personalized treatment interval (PTI) were noninferior to aflibercept for mean change in ...
1. This randomized controlled trial demonstrated that in adult type 2 diabetes patients on daily basal insulin, adding tirzepatide significantly ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.